Post‐transplant ischemic injury is associated with up‐regulated AlloMap gene expression

Abstract:  Background:  The AlloMap gene expression test is used for the non‐invasive detection of rejection. However, the impact of early post‐transplant ischemic injury on subsequent AlloMap gene expression analysis has not been evaluated before.

[1]  T. Klingler,et al.  Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  W. Baumgartner,et al.  Distant Heart Procurement for Human Transplantation: Ultrastructural Studies , 1980, Circulation.

[3]  A. Demetris,et al.  Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. , 1989, Transplantation proceedings.

[4]  Silviu Itescu,et al.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[6]  E. Tuzcu,et al.  Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. , 2002, Journal of the American College of Cardiology.

[7]  R. Starling,et al.  The influence of corticosteroids on the alloimmune molecular signature for cardiac allograft rejection , 2005 .

[8]  E. Tuzcu,et al.  Myocardial Ischemic Injury After Heart Transplantation Is Associated With Upregulation of Vitronectin Receptor (&agr;v&bgr;3), Activation of the Matrix Metalloproteinase Induction System, and Subsequent Development of Coronary Vasculopathy , 2002, Circulation.

[9]  H. Valantine,et al.  Molecular testing in the management of cardiac transplant recipients: initial clinical experience. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.